The important information that hormone receptors are present within the tumor might get lost, as biopsy can only capture a snapshot of a potentially heterogeneous tumor, and after neoadjuvant chemotherapy, no tumor cells might be left. This evidence concerns the gene NR4A1 and neoplasm.